Melissa Palmer, PharmD

Articles by Melissa Palmer, PharmD

tardive dyskinesia assessment and clinical management

Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update

ByMelissa Palmer, PharmD,Austin R. Campbell, PharmD,Amber Finegan, PharmD,Leigh Anne Nelson, PharmD

July 18th 2019

This CME discusses what is known about the pathology of tardive dyskinesia, the risk factors for the disorder, assessment of patients with movement disorders, and diagnosis and treatment.

Latest Updated Articles

Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update
Published: July 18th 2019 | Updated:

Trending on Psychiatric Times

Lecanemab or Lithium for Alzheimer Disease Dementia? New Data Change Everything

Planned FDA Investigational New Drug Application: SPC-15 for the Treatment of PTSD

Polypharmacy in Clozapine-Treated Patients: A Retrospective Analysis

Home

About Us

News